Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Stepan (SCL) EBIT (2016 - 2025)

Stepan's EBIT history spans 16 years, with the latest figure at -$55.5 million for Q4 2025.

  • For Q4 2025, EBIT fell 820.82% year-over-year to -$55.5 million; the TTM value through Dec 2025 reached $12.6 million, down 82.15%, while the annual FY2025 figure was $12.6 million, 82.15% down from the prior year.
  • EBIT reached -$55.5 million in Q4 2025 per SCL's latest filing, down from $21.8 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $77.6 million in Q2 2022 to a low of -$156.0 million in Q4 2022.
  • Average EBIT over 5 years is $17.6 million, with a median of $20.6 million recorded in 2023.
  • Peak YoY movement for EBIT: plummeted 880.2% in 2022, then skyrocketed 3245.65% in 2024.
  • A 5-year view of EBIT shows it stood at $20.0 million in 2021, then tumbled by 880.2% to -$156.0 million in 2022, then soared by 100.15% to $230000.0 in 2023, then surged by 3245.65% to $7.7 million in 2024, then crashed by 820.82% to -$55.5 million in 2025.
  • Per Business Quant, the three most recent readings for SCL's EBIT are -$55.5 million (Q4 2025), $21.8 million (Q3 2025), and $18.0 million (Q2 2025).